Meihua Medical Technologies Co., Ltd. (MHUA) - EV/EBITDA Multiple
MeihuaMed is implementing robotic lines with laser control to eliminate product defects. The company generates revenue through global wholesale supplies of disposable consumables to clinics and dental practices. This chart of current share prices confirms that the EV/EBITDA stands at 0.00. Synergy with international medtech distribution partners optimizes hospital costs, ensuring stable business growth.
Analytical breakdowns for meihuamed.com (MHUA)
- stock price and consensus target price:
- market capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
- business earnings and investment ratios data:
MHUA - Company Net Income|Expected Profit MeihuaMed|MHUA - Price to Earnings Multiple|Projected Price to Earnings Meihua Medical Technologies Co., Ltd.|MHUA - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MHUA|MHUA - Operating income before deduction of amortization|Earnings per share for the last twelve months MeihuaMed|MHUA - Net earnings per share for the last 12 months|Quarterly EPS earnings growth meihuamed.com|MHUA - Earnings per share growth rate in current year|Earnings growth forecast for next year MeihuaMed
Summary company analysis:Meihua Medical (MHUA)
The EV/EBITDA ratio compares the total enterprise value with its operating profit before depreciation and interest, allowing for an assessment of the real value of assets regardless of the tax burden and debt structure. The current value of 0.00, reflected in the EV/EBITDA history of the business, confirms the efficiency of the capital-intensive MeihuaMed (MHUA) ecosystem in ensuring medical sterility through global supplies of consumables.
Competitors of MeihuaMed
Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|AtriCure, Inc. (ATRC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio staar.com|NAGE (ChromaDex Corp.) - EV/EBITDA Multiple|Company Value to EBITDA ZimVie Inc ZIMV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AngioDynamics Corp (ANGO)|Cerus Inc - Enterprise Value to Operating Income Before Depreciation|Alpha Teknova, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio MGRM (monogramorthopedics.com)|STSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio InfuSystem Holdings INFU|Utah Medical (UTMD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio KORU Medical|NYXH (Nyxoah S.A.) - EV/EBITDA Multiple|Company Value to EBITDA microbotmedical.com MBOT|EV/EBITDA Multiple PDEX|Total Company Value to Operating Income Before Depreciation Ratio Zentek Ltd|EV/EBITDA Multiple ELUT (Elutia Corp)|Business Value to Operating Income Before Depreciation MLSS|NXGL: Enterprise Value to EBITDA Ratio|RVP - EV/EBITDA Multiple|HBIO: EV/EBITDA Multiple|Femasys Inc (FEMY) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Predictive Oncology Inc|Enterprise Value to EBITDA Ratio Callan JMB Corp (CJMB)|EV/EBITDA Multiple ATRI|NURO - Company Value to EBITDA
